Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Cutaneous Fistula

ng-nitroarginine methyl ester has been researched along with Cutaneous Fistula in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anic, T; Barisic, I; Berkopic, L; Blagaic, AB; Brcic, I; Brcic, L; Coric, M; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Radic, B; Rokotov, DS; Seiwerth, S; Sever, M; Sikiric, P; Vrcic, H; Vuksic, T; Zoricic, I1
Becejac, T; Brcic, L; Cesarec, V; Djakovic, Z; Drmic, D; Misic, M; Olujic, D; Rokotov, DS; Seiwerth, S; Sikiric, P1

Other Studies

2 other study(ies) available for ng-nitroarginine methyl ester and Cutaneous Fistula

ArticleYear
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.
    Journal of pharmacological sciences, 2008, Volume: 108, Issue:1

    Topics: Anesthesia; Animals; Anti-Ulcer Agents; Arginine; Colonic Diseases; Cutaneous Fistula; Enzyme Inhibitors; Inflammatory Bowel Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar

2008
Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
    European journal of pharmacology, 2013, Feb-15, Volume: 701, Issue:1-3

    Topics: Animals; Arginine; Cutaneous Fistula; Drug Interactions; Esophageal Diseases; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats; Rats, Wistar; Wound Healing

2013